BioHealth News Archive
AstraZeneca to Acquire Neogene Therapeutics, Accelerating Ambition in Oncology Cell Therapy | Business Wire
SANTA MONICA, Calif. & AMSTERDAM--(BUSINESS WIRE)--Neogene Therapeutics, Inc. (Neogene), a global clinical-stage biotechnology company pioneering the discovery, development and manufacturing of next-generation T-cell receptor…
Read More
NIH Wins Licensing Executive Society Deals of Distinction Award for WHO C-TAP Partnership | Technology Transfer
The NIH Technology Transfer Program has won the Licensing Executive Society’s Deals of Distinction award for 2022. The Deals of Distinction Award is given…
Read More
Montgomery County and BioHealth Innovation, Inc. welcome Luis Gutierrez as an “Executive in Residence” to Help Grow County’s Biotech Industry (Updated 11/29)
Updated 11/29 BioHealth Innovation, Inc. (BHI) and Montgomery County are pleased to announce the selection of Luis Gutierrez as a part-time “Executive in Residence”—a…
Read More
Announcing Your 3rd Annual BioBuzz Awards Finalists · BioBuzz
We’re excited to announce this year’s finalists for the third annual 2022 BioBuzz Awards. These awards celebrate the people and companies across our regional community…
Read More
Johns Hopkins Researchers Design ‘Prodrug’ That Targets Cancer Cells’ Big Appetite for Glutamine, Leaving Healthy Cells Unharmed
Johns Hopkins Medicine researchers have revamped an anti-cancer drug to better target cancer cells and leave healthy tissues unharmed. Scientists have dubbed this type…
Read More
Haystack Oncology Inks Lease In Baltimore’s City Garage
Biotechnology firm Haystack Oncology Inc. has signed a lease in the City Garage Science & Technology Center at the recently rebranded Baltimore Peninsula mixed-use development. Haystack, which describes itself…
Read More
QIAGEN launches monkeypox test for NeuMoDx platform to fight global outbreak by boosting research and surveillance | Business Wire
HILDEN, Germany & GERMANTOWN, Maryland--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of the monkeypox (MPXV) test for its…
Read More
MacroGenics Earns $60 Million Milestone with U.S. FDA Approval of Teplizumab
ROCKVILLE, MD, Nov. 17, 2022 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused on developing and commercializing innovative antibody-based therapeutics for the treatment of…
Read More
On the Road Montgomery County: Biotech boom not happening everwhere – Washington Business Journal
In Montgomery County, lab space has long been a prized get for biotechs, because there was so little of it. Shockingly little, actually, given the county…
Read More
The Princeton Review & Entrepreneur Magazine Name the Top Undergrad & Grad Schools for Entrepreneurship Studies for 2023 – University of Maryland ranked in Top 10
NEW YORK, Nov. 15, 2022 /PRNewswire/ -- The Princeton Review® and Entrepreneur® today announced the results of The Princeton Review's 17th annual ranking of undergraduate…
Read More
Money Moves: Baltimore nanotech firm Pixelligent raised a sparkly new $38M – Technical.ly
Pixelligent, a nanotechnology firm that produces materials used in augmented reality displays and sensors, recently raised $38 million in IP-backed financing from a funding vehicle…
Read More
Chicago’s roadmap to becoming the next big life sciences city – REJournals
According to a recent report from CBRE, Chicago ranks No. 6 for job growth out of the Top 25 life sciences markets in the…
Read More
Deadline for Medtech Innovator Applications is January 31, 2023 – The LaunchPort
Apply Now for Our 2023 Programs! Applications for our three different Innovator programs – MedTech Innovator US, MedTech Innovator Asia Pacific, and BioTools Innovator –…
Read More
Emergent scores a DoD award to evaluate its chikungunya vaccine in the field – Endpoints News
Emergent BioSolutions is looking to make progress with its chikungunya vaccine and has received a $10 million US government grant to help it along.…
Read More
Building and sustaining public trust in science – The Washington Post
The coronavirus pandemic has underlined the value of clearly communicating scientific data, public health guidance and risk factors amidst uncertainty. On Tuesday, Dec. 6…
Read More